MedTrace Logo

Correcting Disinformation About Menthol Cigarettes and Flavored Cigars

NCT07543081 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-05-05

No results posted yet for this study

Summary

Our study tests a multi-level anti- disinformation message (ADM) campaign on menthol cigarette and flavored cigar policies in Black adults.

Conditions

  • Disinformation
  • Menthol Cigarettes
  • Flavored Cigars

Interventions

BEHAVIORAL

Individual delivery of anti-disinformation messaging

Participants in this condition will be exposed to anti-disinformation messages (ADM) designed to increase correct beliefs about menthol cigarettes, flavored cigars, the purpose, and limits of flavored tobacco policies. The delayed intervention control condition in this study will receive the ADM intervention after outcome measures are collected at the last assessment.

BEHAVIORAL

Community delivery of anti-disinformation messaging

Our community-level campaign will distribute our ADM messages to our Intervention Community via social media, print ads and posters, radio ads, and community events. These messages will be delivered over 1 year, with monthly delivery activities led by EAB members in the Intervention Community.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Andrea C Villanti, PhD, MPH · Rutgers University

  • Kymberle L Sterling, DrPH · Rutgers University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07543081 on ClinicalTrials.gov